The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies

被引：11
|
作者：
Norman, Jane E. [1 ]
Schouten, Harry C. [2 ]
Dreger, Peter [3 ]
Robinson, Stephen P. [4 ]
机构：
[1] Manchester Royal Infirm, Dept Haematol, Manchester, Lancs, England
[2] Univ Hosp Maastricht, Dept Internal Med Hematol, Maastricht, Netherlands
[3] Heidelberg Univ, Dept Haematol & Oncol, Heidelberg, Germany
[4] Bristol Oncol & Haematol Ctr, Dept Haematol, Bristol, Avon, England
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷 / 06期
关键词：
NON-HODGKIN-LYMPHOMA; TERM-FOLLOW-UP; BONE-MARROW-TRANSPLANTATION; PROGRESSION-FREE SURVIVAL; HIGH-DOSE THERAPY; CHRONIC LYMPHOCYTIC-LEUKEMIA; CHIMERIC-ANTIGEN-RECEPTOR; LOW-GRADE; OPEN-LABEL; PHASE-II;
D O I：
10.1038/s41409-018-0372-5
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Patients with relapsed follicular lymphoma (FL) following first-line therapy have an increasing number of management strategies ranging from observation through to stem cell transplantation. There has been an exciting expansion in novel agents to treat FL, but at present there is not a universally accepted standard of care in the relapse setting. Decision-making can be difficult for the clinician as there is a paucity of data to compare the various relapse therapies available. This review will discuss conventional therapy for relapsed FL, consider the use of novel agents and explore the role and timing of autologous and allogeneic stem cell transplantation.
引用
收藏
页码：787 / 797
页数：11
相关论文
共 50 条
  • [1] The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies
    Jane E. Norman
    Harry C. Schouten
    Peter Dreger
    Stephen P. Robinson
    Bone Marrow Transplantation, 2019, 54 : 787 - 797
  • [2] The role of stem cell transplantation in follicular lymphoma
    Hess, Georg
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (01) : 31 - 40
  • [3] Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era
    Sesques, Pierre
    Bourcier, Jessie
    Golfier, Camille
    Lebras, Laure
    Nicolas-Virelizier, Emmanuelle
    Hacini, Maya
    Perrin, Marie Claire
    Voillat, Laurent
    Bachy, Emmanuel
    Traverse-Glehen, Alexandra
    Moreau, Anne
    Martin, Laurent
    Ramla, Selim
    Casasnovas, Olivier
    Le Gouill, Steven
    Salles, Gilles
    Ghesquieres, Herve
    HEMATOLOGICAL ONCOLOGY, 2020, 38 (02) : 137 - 145
  • [4] The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era
    Maura, Francesco
    Farina, Lucia
    Corradini, Paolo
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2016, 8
  • [5] Hematopoietic stem cell transplantation for the management of follicular lymphoma
    Hosing, Chitra
    STEM CELLS AND CLONING-ADVANCES AND APPLICATIONS, 2010, 3 : 69 - 80
  • [6] The role of stem cell transplantation in the treatment of follicular lymphoma
    Finke, R
    SEMINARS IN CANCER BIOLOGY, 2003, 13 (03) : 233 - 239
  • [7] Changing role of stem cell transplantation in follicular lymphoma
    Laport, Ginna G.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, : 417 - 425
  • [8] Outpatient autologous stem cell transplantation for patients with relapsed follicular lymphoma.
    Leger, CS
    Sabloff, M
    Atkins, H
    Bence-Bruckler, I
    Bredeson, C
    McDiarmid, S
    Hopkins, H
    Huebsch, L
    BLOOD, 2002, 100 (11) : 472B - 472B
  • [9] Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma
    Leger, Chantal
    Sabloff, Mitchell
    McDiarmid, Sheryl
    Bence-Bruckler, Isabelle
    Atkins, Harry
    Bredeson, Christopher
    Zhang, Hongbin
    Huebsch, Lothar
    ANNALS OF HEMATOLOGY, 2006, 85 (10) : 723 - 729
  • [10] Stem Cell Transplantation for Follicular Lymphoma Relapsed/Refractory After Prior Rituximab
    Evens, Andrew M.
    Vanderplas, Ann
    LaCasce, Ann S.
    Crosby, Allison L.
    Nademanee, Auayporn P.
    Kaminski, Mark S.
    Abel, Gregory A.
    Millenson, Michael
    Czuczman, Myron S.
    Rodriguez, Maria A.
    Niland, Joyce
    Zelenetz, Andrew D.
    Gordon, Leo I.
    Friedberg, Jonathan W.
    CANCER, 2013, 119 (20) : 3662 - 3671
12345